Tata Chemicals fell 2% ahead of Q1 results, with analyst Deepak Pal flagging ₹990 as key resistance. The stock appears overvalued, with weakening momentum indicators and low RoE. While long-term potential remains, short-term traders are advised to exercise caution. A dip to ₹850 may offer a better entry for investors if earnings disappoint.